February 13, 2026 – Baxter Worldwide Inc. stories outcomes for the fourth quarter of 2025.

“Whereas we delivered income progress throughout all segments, our fourth quarter outcomes fell wanting our expectations, underscoring the significance of our concentrate on driving steady enchancment throughout the enterprise,” stated Andrew Hider, president and CEO. “We lately launched a brand new working mannequin designed to simplify our group, speed up innovation and enhance efficiency. These adjustments additional decentralize the enterprise and embed vital practical roles straight inside every division, bringing us nearer to our prospects and finally serving to us enhance our say-to-do ratio and execute extra persistently. Whereas the work forward will take time, I’m inspired by the dedication of our staff and stay assured in Baxter’s long-term trajectory.”

Monetary outcomes for the fourth quarter of 2025, company-wide

Please notice that persevering with operations exclude Baxter’s Kidney Care enterprise, which was acquired by Carlyle in January 2025 and are reported as discontinued operations.

• International income from persevering with operations within the fourth quarter was roughly $2.97 billion, up 8% on a reported foundation and three% on an operational foundation.
• U.S. income from persevering with operations within the fourth quarter was roughly $1.55 billion, up 3% on a reported foundation and down 1% on an working foundation.
• Worldwide income from persevering with operations within the fourth quarter was roughly $1.42 billion, up 14% on a reported foundation and eight% on an operational foundation.
• On a US GAAP foundation, internet earnings (loss) from persevering with operations totaled ($1,035) million, or ($2.01) per diluted share, together with a goodwill impairment cost of $485 million associated to the Entrance Line Care reporting unit and an impairment cost on the recoverability of US deferred tax belongings of $330 million.
• On an adjusted foundation, internet earnings from persevering with operations within the fourth quarter was $0.44 per diluted share, down 24% from the prior yr, primarily because of an unfavorable product combine, one-time objects together with stock changes, and a better efficient tax fee.

Learn extra from Baxter Worldwide Inc.